Schedule 13G ownership disclosure
ACCENTIA BIOPHARMACEUTICALS
Security class unavailable · CUSIP: 00430L103
Event date: 2015-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,285,257
- Percent of class
- 13.6900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001457716-15-000025
- Form type
- SC 13G
- Filer
- ACCENTIA BIOPHARMACEUTICALS INC
- CIK
- CIK 1310094
- Filed
- Aug 10, 2015
- Reporting period
- Jul 31, 2015
- Description
- Schedule 13G beneficial ownership